Elbaylek Hamza, Ammor Soumia
Department of Biology, Laboratory of Pharmacology, Neurobiology, Anthropobiology and Environment, Faculty of Sciences Semlalia University Cadi Ayyad, Marrakech, Morocco.
Asian Pac J Cancer Prev. 2025 Jun 1;26(6):2225-2232. doi: 10.31557/APJCP.2025.26.6.2225.
Colorectal cancer (CRC) encompasses both non-modifiable and modifiable risk factors. While diet remains the main factor influencing CRC risk, hormonal and reproductive factors have also demonstrated a potential impact on CRC risk. This study aims to explore the relationship between oral contraceptives (OC) use and Colorectal cancer risk among Moroccan women.
We conducted a case-control study included 300 participants, divided into 150 cases and 150 controls matched by age (± 3 years). Through a face-to-face interview with trained investigators, we collected data on oral contraceptives use among participants. we performed conditional logistic regression to estimate Odds Ratio (OR) and 95% confidence interval (95% CI), to elaborate a basic model and adjusted model for confounding factors to assess the relationship between OC use and CRC risk.
An inverse correlation was observed between OC use and CRC risk with OR:0.57 (0.36-0.92), using OC at younger ages (≤24 years) for a longer period (>8 years) was also associated with a decreased risk of CRC, with OR: 0.52 (0.31-0.89) and OR: 0.43 (0.26-0.79), respectively. this association was consistent across all tumor location in the adjusted model, with OR: 0.54 (0.27-0.98) for colon cancer, OR: 0.47 (0.21-0.96) for rectal cancer, and OR: 0.35 (0.12-0.9) for colorectal cancer. Furthermore, combined oral contraceptives use significantly reduced CRC risk, with OR: 0.42 (0.21-0.75), whereas no significant reduction was observed with progestin-only pills with OR: 0.64 (0.32-1.17).
These findings underscore the potential role of reproductive and hormone factors, such as oral contraceptive use, in reducing colorectal cancer risk, particularly for combined oral contraceptives initiated in a younger age, also the importance of incorporating reproductive and hormone factors in future research in Morocco, providing a broader understanding of colorectal cancer prevention strategies.
结直肠癌(CRC)包含不可改变和可改变的风险因素。虽然饮食仍然是影响结直肠癌风险的主要因素,但激素和生殖因素也已证明对结直肠癌风险有潜在影响。本研究旨在探讨摩洛哥女性口服避孕药(OC)的使用与结直肠癌风险之间的关系。
我们进行了一项病例对照研究,纳入300名参与者,分为150例病例和150名对照,按年龄(±3岁)匹配。通过与经过培训的调查人员进行面对面访谈,我们收集了参与者口服避孕药使用的数据。我们进行条件逻辑回归以估计比值比(OR)和95%置信区间(95%CI),构建一个基本模型并针对混杂因素进行调整模型,以评估OC使用与结直肠癌风险之间的关系。
观察到OC使用与结直肠癌风险之间呈负相关,OR为0.57(0.36 - 0.92),在较年轻年龄(≤24岁)使用OC较长时间(>8年)也与结直肠癌风险降低相关,OR分别为0.52(0.31 - 0.89)和0.43(0.26 - 0.79)。在调整模型中,这种关联在所有肿瘤部位均一致,结肠癌的OR为0.54(0.27 - 0.98),直肠癌的OR为0.47(0.21 - 0.96),结直肠癌的OR为0.35(0.12 - 0.9)。此外,复方口服避孕药的使用显著降低了结直肠癌风险,OR为0.42(0.21 - 0.75),而仅含孕激素的避孕药未观察到显著降低,OR为0.64(0.32 - 1.17)。
这些发现强调了生殖和激素因素,如口服避孕药的使用,在降低结直肠癌风险方面的潜在作用,特别是对于较年轻年龄开始使用的复方口服避孕药,也强调了在摩洛哥未来研究中纳入生殖和激素因素的重要性,从而对结直肠癌预防策略有更广泛的理解。